Office | EPO |
Document type: | Patent |
Inventor(s): | Wagner José Fávaro; Nelson Eduardo Durán Caballero |
Applicant: | Universidade Estadual de Campinas Unicamp |
Year: | 2021 |
Application Number: | EP21210111 |
IPC: | A61K 33/02 A61K 33/06 A61K 33/42 A61K 38/00 A61P 35/00 C01B 25/34 |
The present invention relates to a method of obtaining an inorganic nanostructured complex (CFI-1), a protein-associated nanostructured complex (MRB-CF1-1) and antitumor use. The main use is in treating urinary bladder cancer, both in animals and humans. The complex has singular antitumor activity, and can potentially be used as a substitute and/or act as an adjuvant for other commercial antineoplastic drugs.
FAPESP's process: | 17/04383-2 - New therapeutic perspective for non-muscle invasive bladder Cancer: use of the biological response modifier - inorganic phosphate complex 1 (MRB-CFI-1) |
Grantee: | Melissa Sena da Silva |
Principal Investigator: | Wagner José Fávaro |
Institution: | Universidade Estadual de Campinas (UNICAMP). Instituto de Biologia (IB) |
Support Opportunities: | Scholarships in Brazil - Scientific Initiation |